Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
SQI Diagnostics Inc is a Canada-based company engaged in developing and commercializing proprietary technologies & products for multiplexing diagnostics. The company develops multiplexed blood tests to enable simultaneous measurement of molecules like proteins, antibodies, and inflammatory biomarkers. Currently, it is focusing on business units targeting organ transplant, autoimmune disease, and serological testing. Its geographical segments are the United States, Canada, Europe, and the Rest of the World. More than half of the revenue comes from the United States.
Toronto, ON, M9W 1A4, Canada